Tilray Brands, Inc. (TLRY)
Automate Your Wheel Strategy on TLRY
With Tiblio's Option Bot, you can configure your own wheel strategy including TLRY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TLRY
- Rev/Share 1.0196
- Book/Share 1.4342
- PB 0.9772
- Debt/Equity 0.1501
- CurrentRatio 2.6198
- ROIC -1.6144
- MktCap 1586733164.0
- FreeCF/Share -0.1129
- PFCF -13.2555
- PE -0.5008
- Debt/Assets 0.1111
- DivYield 0
- ROE -0.9686
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands (TLRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Should You Buy TLRY Stock After Encouraging Q1 Results?
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray's return to profitability, stronger cash flow, and expanding global cannabis and beverage operations highlight its renewed growth story.
Read More
Delta, Pepsi, Applied Digital, Levi's, Tilray Brands kick off Q3 earnings season
Published: October 10, 2025 by: Proactive Investors
Sentiment: Neutral
This week marked the start of earnings season with several major companies reporting results, including Delta Air Lines and PepsiCo, while the big banks like JPMorgan Chase, Citigroup, and Wells Fargo are set to report next week. Investors are closely watching these early reports for cues on the broader economic landscape amid ongoing uncertainties.
Read More
Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Tilray Brands, Inc. (NASDAQ:TLRY ) Q1 2026 Earnings Call October 9, 2025 8:30 AM EDT Company Participants Berrin Noorata - Chief Corporate Affairs Officer Irwin Simon - President, CEO & Chairman Carl Merton - CFO & Principal Accounting Officer Lloyd Brathwaite - Chief Information Officer Blair MacNeil - President of Tilray Canada Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Xin Ma - TD Cowen, Research Division Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Presentation Operator Thank you for joining today's conference call to discuss …
Read More
Tilray: Another Blah Quarter
Published: October 09, 2025 by: Seeking Alpha
Sentiment: Positive
Tilray Brands surged after FQ1 results, but the business shows minimal growth and is no longer focused on key cannabis sales. TLRY's revenue growth was driven mainly by acquisitions and currency gains, not organic expansion, with weak margins and declining beverage sales. The stock's rally is based on U.S. cannabis rescheduling hopes, yet TLRY lacks exposure to the U.S. cannabis market and trades at a high valuation at 36x adj. EBITDA forecasts.
Read More
Q3 Earnings Season Begins On Positive Note
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Pre-market earnings are flat-to-down at this hour, following another robust session Wednesday, led by an expanding AI trade and climbing gold values that have brought market indexes up double-digits from April lows. The Dow is -16 points, the S&P 500 +1 and the Nasdaq -4 points.
Read More
Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt
Published: October 09, 2025 by: Benzinga
Sentiment: Positive
Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.
Read More
Tilray Brands stock surges as cannabis company posts Q1 profit
Published: October 09, 2025 by: Proactive Investors
Sentiment: Positive
Tilray Inc (NASDAQ:TLRY) shares climbed 15% to US$1.98 in early trading on Thursday after the cannabis company announced that it swung to an adjusted net profit of $3.9 million for its fiscal first quarter 2025, from loss of $6.1 million during the same period last year. Its net revenue for the quarter rose 5% to $209.5 million, boosted by a 12% year over year increase in Canadian adult-use cannabis sales and 10% growth in international cannabis revenue.
Read More
Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q1
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
Tilray Brands, Inc. (TLRY) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.04 per share a year ago.
Read More
TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus
Published: October 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' fiscal first-quarter report is likely to highlight international cannabis gains, European expansion and wellness growth.
Read More
Trump's CBD Video Sparks Buzz: 3 Cannabis Stocks to Watch
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Trump's CBD video fuels momentum in cannabis, with Village Farms, Canopy Growth, and Tilray emerging as stocks to watch in 2025.
Read More
Tilray stock price forecast as it faces major headwinds
Published: September 30, 2025 by: Invezz
Sentiment: Negative
Tilray stock price has surged in the past few weeks, with most of the gains happening on Monday when it surged by over 60%, which brought its market capitalization to over $2 billion. It has now soared by over 440% from its lowest level this year.
Read More
Best Canadian Cannabis Stocks to Watch for Growth and Opportunity
Published: September 30, 2025 by: MarijuanaStocks
Sentiment: Positive
The U.S. cannabis industry has expanded rapidly, now generating over $33 billion in annual sales. Analysts project the market could exceed $56 billion by 2030. These figures highlight the growing opportunities for Canadian cannabis companies to target U.S. partnerships and eventual federal legalization. Recently, U.S. lawmakers renewed discussions about rescheduling cannabis under federal law. This sparked optimism and short-term volatility across cannabis stocks. Canadian firms remain positioned to benefit from regulatory progress and expanding cross-border demand. Their strategies include scaling production, diversifying product lines, and investing in branded distribution. As the industry evolves rapidly, investors must closely monitor these developments.
Read More
Wall Street Breakfast Podcast: Weed Stocks Light Up
Published: September 30, 2025 by: Seeking Alpha
Sentiment: Positive
Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double digits, with related ETFs MSOS and MJ also posting significant gains.
Read More
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
Published: September 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray's EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray's ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical …
Read More
Markets Keep at All-Time Highs - Lots of Data Expected This Week
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Pending Homes Sales were better than expected, and cannabis stocks got a boost. But there is a lot of grist for the mill coming out in the coming days.
Read More
Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD
Published: September 29, 2025 by: New York Post
Sentiment: Positive
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.
Read More
Tilray Brands: What's Next For TLRY Stock?
Published: September 24, 2025 by: Forbes
Sentiment: Positive
Tilray Brands (NASDAQ: TLRY) has witnessed a considerable surge, rising nearly 200% from $0.42 in early July to its present price of $1.24. This increase is largely attributed to the Trump administration's deliberation on reclassifying cannabis from a Schedule I to a Schedule III substance.
Read More
Tilray stock price sits and waits for Trump cannabis rescheduling
Published: September 17, 2025 by: Invezz
Sentiment: Neutral
The Tilray Brands stock price has staged a strong bullish rebound in the past few months, moving from a low of $0.352 in June to $1.25, up by 256%. Here's what to expect as market participants wait for the cannabis rescheduling.
Read More
Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release
Published: September 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NANAIMO, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer-packaged goods company, announced that its premium craft cannabis brand Broken Coast is launching BC Selects, a new limited-edition line of premium cannabis flower that features unique phenotypes from its proprietary genetic library. The first strain in this series, Sprits 26, is now available exclusively in British Columbia, underscoring Broken Coast's dedication to precision and excellence in craft cannabis production.
Read More
3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025
Published: September 03, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry continues to demonstrate why it deserves the same opportunities as other legitimate businesses. From an investment side, there are many who have put up big money in various global regions to be a part of this booming industry. Places like Canada and the USA are where the main markets exist. Now there are several parts to this, both bitter and sweet. Here is why it could be a bit bitter is with the potential of cannabis being rescheduled, it will give a major leg up to corporate cannabis versus small batch mom and pop cultivators.
Read More
Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
Published: August 29, 2025 by: 24/7 Wall Street
Sentiment: Neutral
Key Points in This Article: Cannabis stocks surged in 2018-2019 on federal legalization hopes but crashed as progress stalled.
Read More
Tilray Brands shares gain as analysts boost price target on cannabis rescheduling optimism
Published: August 26, 2025 by: Proactive Investors
Sentiment: Positive
Tilray Brands (NASDAQ:TLRY) shares continued to gain momentum on Tuesday after the cannabis firm saw its price target boosted by Jefferies analysts. The analysts, who maintained a ‘Buy' rating on Tilray, upped their price target to $2 from $1.50, citing growing optimism about a potential shift in US federal cannabis policy.
Read More
Top Canadian Marijuana Stocks to Watch in 2025 : Industry Growth and Legalization Updates
Published: August 26, 2025 by: MarijuanaStocks
Sentiment: Positive
Investors are closely watching Canadian cannabis stocks this week amid rising U.S. industry momentum. The U.S. cannabis market hit an estimated $38.5 billion in 2024 and may grow at a compound annual growth rate (CAGR) of about 11–12 percent through the late 2020s. Meanwhile, several states are advancing reform. Notably, Delaware began adult-use cannabis sales on August 1, 2025. Moreover, at the federal level, the Trump administration signaled plans to reschedule marijuana from Schedule I to Schedule III, possibly within weeks. This could ease restrictions and boost stock sentiment. Altogether, these developments underline strong thematic tailwinds. Thus, Canadian cannabis stocks …
Read More
Tilray Brands: Path To 5x Growth For TLRY Stock
Published: August 26, 2025 by: Forbes
Sentiment: Positive
Tilray Brands (NASDAQ: TLRY) stock has already climbed 2x in the past month after reports that the Trump administration may reclassify marijuana, underscoring the market's recognition of this transformative catalyst. But how significant could this opportunity become for Tilray?
Read More
Tilray's High Hopes: The Catalyst Driving Cannabis Stocks
Published: August 21, 2025 by: MarketBeat
Sentiment: Positive
A fairly consistent climb in Tilray Brands' NASDAQ: TLRY stock price has started to capture the market's attention. After touching a 52-week low of 35 cents, the stock has rallied dramatically, climbing over 133% in the last three months on massive trading volume.
Read More
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.03, denoting a -12.71% move from the preceding trading day.
Read More
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Published: August 14, 2025 by: Seeking Alpha
Sentiment: Positive
Tilray Brands: Improving Fundamentals, De-Risked Balance Sheet, And A Re-Igniting Narrative
Read More
Cannabis stocks surge as Trump consider reclassifying the drug
Published: August 11, 2025 by: Proactive Investors
Sentiment: Positive
Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a Schedule I drug, along with heroin and cocaine, to Schedule III.
Read More
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
Published: August 11, 2025 by: CNBC
Sentiment: Positive
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the industry, one investing chief said.
Read More
About Tilray Brands, Inc. (TLRY)
- IPO Date 2018-07-19
- Website https://www.tilray.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Irwin David Simon
- Employees 2650